What do studies say about CRP Basis?

CRP (C-reactive protein) is a well-established marker of inflammation, used clinically to detect acute or chronic inflammatory states. High-sensitivity CRP (hsCRP) is specifically employed for cardiovascular risk assessment. Studies indicate that elevated hsCRP levels are associated with increased risk of heart attack and stroke, but CRP is not a standalone predictor – it must be interpreted alongside other risk factors such as LDL cholesterol, blood pressure, and smoking. The evidence base is largely observational (human-moderate). Genetic variants (e.g., in the CRP gene) can influence baseline CRP levels, complicating interpretation. Importantly, a single elevated CRP value without clinical symptoms does not warrant specific therapy; it serves as a signal, not a diagnosis. For comprehensive risk evaluation, repeated measurements and medical follow-up are necessary. The MyBody-X Cardio Risk Check includes hsCRP as one of several markers but emphasizes that the test cannot predict heart attacks.